Literature DB >> 24513023

Late, not early, stages of Kanizsa shape perception are compromised in schizophrenia.

Brian P Keane1, Jamie Joseph2, Steven M Silverstein3.   

Abstract

BACKGROUND: Schizophrenia is a devastating psychiatric disorder characterized by symptoms including delusions, hallucinations, and disorganized thought. Kanizsa shape perception is a basic visual process that builds illusory contour and shape representations from spatially segregated edges. Recent studies have shown that schizophrenia patients exhibit abnormal electrophysiological signatures during Kanizsa shape perception tasks, but it remains unclear how these abnormalities are manifested behaviorally and whether they arise from early or late levels in visual processing.
METHOD: To address this issue, we had healthy controls and schizophrenia patients discriminate quartets of sectored circles that either formed or did not form illusory shapes (illusory and fragmented conditions, respectively). Half of the trials in each condition incorporated distractor lines, which are known to disrupt illusory contour formation and thereby worsen illusory shape discrimination.
RESULTS: Relative to their respective fragmented conditions, patients performed worse than controls in the illusory discrimination. Conceptually disorganized patients-characterized by their incoherent manner of speaking-were primarily driving the effect. Regardless of patient status or disorganization levels, distractor lines worsened discrimination more in the illusory than the fragmented condition, indicating that all groups could form illusory contours.
CONCLUSION: People with schizophrenia form illusory contours but are less able to utilize those contours to discern global shape. The impairment is especially related to the ability to think and speak coherently. These results suggest that Kanizsa shape perception incorporates an early illusory contour formation stage and a later, conceptually-mediated shape integration stage, with the latter being compromised in schizophrenia.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Conceptual disorganization; Illusory contours; Kanizsa shape perception; Schizophrenia; Thought disorder; Visual completion

Mesh:

Year:  2014        PMID: 24513023      PMCID: PMC4103877          DOI: 10.1016/j.neuropsychologia.2014.02.001

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  86 in total

1.  Deriving behavioural receptive fields for visually completed contours.

Authors:  J M Gold; R F Murray; P J Bennett; A B Sekuler
Journal:  Curr Biol       Date:  2000-06-01       Impact factor: 10.834

2.  Time course of amodal completion revealed by a shape discrimination task.

Authors:  R F Murray; A B Sekuler; P J Bennett
Journal:  Psychon Bull Rev       Date:  2001-12

Review 3.  Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia.

Authors:  Kwang-Hyuk Lee; Leanne M Williams; Michael Breakspear; Evian Gordon
Journal:  Brain Res Brain Res Rev       Date:  2003-01

4.  The clinical translation of a measure of gain control: the contrast-contrast effect task.

Authors:  Deanna M Barch; Cameron S Carter; Steve C Dakin; James Gold; Steven J Luck; Angus Macdonald; John D Ragland; Steven Silverstein; Milton E Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

5.  Attentional signatures of perception: multiple object tracking reveals the automaticity of contour interpolation.

Authors:  Brian P Keane; Everett Mettler; Vicky Tsoi; Philip J Kellman
Journal:  J Exp Psychol Hum Percept Perform       Date:  2011-06       Impact factor: 3.332

6.  Contour integration across polarities and spatial gaps: from local contrast filtering to global grouping.

Authors:  B Dresp; S Grossberg
Journal:  Vision Res       Date:  1997-04       Impact factor: 1.886

7.  The spatial range of contour integration deficits in schizophrenia.

Authors:  Brian P Keane; Steven M Silverstein; Deanna M Barch; Cameron S Carter; James M Gold; Ilona Kovács; Angus W MacDonald; J Daniel Ragland; Milton E Strauss
Journal:  Exp Brain Res       Date:  2012-06-19       Impact factor: 1.972

8.  Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

Authors:  Nancy C Andreasen; Marcus Pressler; Peg Nopoulos; Del Miller; Beng-Choon Ho
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

9.  Reinterpreting behavioral receptive fields: lightness induction alters visually completed shape.

Authors:  Brian P Keane; Hongjing Lu; Thomas V Papathomas; Steven M Silverstein; Philip J Kellman
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

10.  Sex, symptom, and premorbid social functioning associated with perceptual organization dysfunction in schizophrenia.

Authors:  Jamie Joseph; Grace Bae; Steven M Silverstein
Journal:  Front Psychol       Date:  2013-08-27
View more
  13 in total

Review 1.  Neural mechanisms underlying visual and auditory processing impairments in schizophrenia: insight into the etiology and implications for tailoring preventive and therapeutic interventions.

Authors:  Chuanjun Zhuo; Hongjun Tian; Tao Fang; Ranli Li; Yachen Li; Lingguang Kong; Ziyao Cai; Lidan Zheng; Xiaodong Lin; Ce Chen
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

2.  Multiple forms of contour grouping deficits in schizophrenia: what is the role of spatial frequency?

Authors:  Brian P Keane; Gennady Erlikhman; Sabine Kastner; Danielle Paterno; Steven M Silverstein
Journal:  Neuropsychologia       Date:  2014-11-01       Impact factor: 3.139

3.  Cortical contributions to impaired contour integration in schizophrenia.

Authors:  Steven M Silverstein; Michael P Harms; Cameron S Carter; James M Gold; Brian P Keane; Angus MacDonald; J Daniel Ragland; Deanna M Barch
Journal:  Neuropsychologia       Date:  2015-07-06       Impact factor: 3.139

4.  A brief psychometric test reveals robust shape completion deficits in schizophrenia that are less severe in bipolar disorder.

Authors:  Brian P Keane; Gennady Erlikhman; Megan Serody; Steven M Silverstein
Journal:  Schizophr Res       Date:  2021-12-30       Impact factor: 4.939

5.  Reduced influence of perceptual context in schizophrenia: behavioral and neurophysiological evidence.

Authors:  Victor J Pokorny; Timothy J Lano; Michael-Paul Schallmo; Cheryl A Olman; Scott R Sponheim
Journal:  Psychol Med       Date:  2019-12-20       Impact factor: 7.723

6.  Aberrant Cortical Connectivity During Ambiguous Object Recognition Is Associated With Schizophrenia.

Authors:  Victor J Pokorny; Tori D Espensen-Sturges; Philip C Burton; Scott R Sponheim; Cheryl A Olman
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-10-10

7.  EEG findings of reduced neural synchronization during visual integration in schizophrenia.

Authors:  Jonathan K Wynn; Brian J Roach; Junghee Lee; William P Horan; Judith M Ford; Amy M Jimenez; Michael F Green
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

8.  Local and global limits on visual processing in schizophrenia.

Authors:  Marc S Tibber; Elaine J Anderson; Tracy Bobin; Patricia Carlin; Sukhwinder S Shergill; Steven C Dakin
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

9.  Disruptions in neural connectivity associated with reduced susceptibility to a depth inversion illusion in youth at ultra high risk for psychosis.

Authors:  Tina Gupta; Steven M Silverstein; Jessica A Bernard; Brian P Keane; Thomas V Papathomas; Andrea Pelletier-Baldelli; Derek J Dean; Raeana E Newberry; Ivanka Ristanovic; Vijay A Mittal
Journal:  Neuroimage Clin       Date:  2016-10-02       Impact factor: 4.881

10.  Hierarchical Classes Analysis (HICLAS): A novel data reduction method to examine associations between biallelic SNPs and perceptual organization phenotypes in schizophrenia.

Authors:  Jamie Joseph; Michael A Gara; Steven M Silverstein
Journal:  Schizophr Res Cogn       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.